Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haematologic Disease (Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01865617
What this trial is testing

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Who this might be right for
CD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more
Fred Hutchinson Cancer Center 204
Large-scale testing (Phase 3)Not Yet RecruitingNCT07735117
What this trial is testing

Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
Ruijin Hospital 168
Early research (Phase 1)Study completedNCT00047489
What this trial is testing

Study of ABT-751 in Patients With Refractory Hematologic Malignancies

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 32
Not applicableStudy completedNCT00969891
What this trial is testing

Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Mikkel Krogh-Madsen 23
Not applicableEnded earlyNCT00513318
What this trial is testing

Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more
University of California, San Francisco 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06858618
What this trial is testing

FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms

Who this might be right for
SafetyAntitumor ActivityPK Profile
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 47
Testing effectiveness (Phase 2)UnknownNCT01016990
What this trial is testing

Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Auxilio Mutuo Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT00797758
What this trial is testing

Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Testing effectiveness (Phase 2)UnknownNCT04082910
What this trial is testing

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

Who this might be right for
Solid TumorHematological Malignancy
Chinese PLA General Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT05726110
What this trial is testing

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
Shanxi Bethune Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00065143
What this trial is testing

Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
M.D. Anderson Cancer Center 60
Not applicableLooking for participantsNCT06907797
What this trial is testing

Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

Who this might be right for
Acute LeukemiaLeukemia
Dana-Farber Cancer Institute 75
Large-scale testing (Phase 3)Study completedNCT00136084
What this trial is testing

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

Who this might be right for
Leukemia, Myelocytic, Acute
St. Jude Children's Research Hospital 238
Early research (Phase 1)Looking for participantsNCT07020533
What this trial is testing

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center 46
Testing effectiveness (Phase 2)Study completedNCT00899847
What this trial is testing

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Who this might be right for
Transplantation, HomologousTransplantation, AutologousMultiple Myeloma+1 more
Stanford University 9
Testing effectiveness (Phase 2)Ended earlyNCT01573247
What this trial is testing

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akinion Pharmaceuticals AB 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980885
What this trial is testing

A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akeso 68
Testing effectiveness (Phase 2)Looking for participantsNCT06517017
What this trial is testing

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
University of Utah 40
Early research (Phase 1)Study completedNCT05470140
What this trial is testing

WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Allotera Therapeutics 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT01885689
What this trial is testing

Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in Remission+4 more
City of Hope Medical Center
Next Page
72